Biogen (BIIB) Gross Margin (QoQ) (2009 - 2026)
Biogen (BIIB) Gross Margin (QoQ) (2009 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Gsk |
96,436,181.12 Bn |
96,436,176.16 Bn |
7.76 Bn |
| 2 |
Eli Lilly |
1,017.30 Bn |
1,012.01 Bn |
16.22 Bn |
| 3 |
Johnson & Johnson |
579.61 Bn |
557.55 Bn |
15.96 Bn |
| 4 |
AbbVie |
402.30 Bn |
392.96 Bn |
10.78 Bn |
| 5 |
Merck |
294.24 Bn |
288.59 Bn |
12.09 Bn |
| 6 |
Amgen |
191.82 Bn |
179.78 Bn |
5.87 Bn |
| 7 |
Gilead Sciences |
155.93 Bn |
148.21 Bn |
5.52 Bn |
| 8 |
Pfizer |
149.05 Bn |
136.28 Bn |
-1.21 Bn |
| 9 |
Bristol Myers Squibb |
116.33 Bn |
105.88 Bn |
8.07 Bn |
| 10 |
Biogen |
29.43 Bn |
25.15 Bn |
1.82 Bn |
| Date | Value |
|---|
| Mar 31, 2026 |
-494.00 |
| Dec 31, 2025 |
487.00 |
| Sep 30, 2025 |
-374.00 |
| Jun 30, 2025 |
302.00 |
| Mar 31, 2025 |
-212.00 |
| Dec 31, 2024 |
213.00 |
| Sep 30, 2024 |
-375.00 |
| Jun 30, 2024 |
152.00 |
| Mar 31, 2024 |
-1,680.00 |
| Dec 31, 2023 |
1,920.00 |
| Sep 30, 2023 |
-194.00 |
| Jun 30, 2023 |
278.00 |
| Mar 31, 2023 |
-2,046.00 |
| Dec 31, 2022 |
1,227.00 |
| Sep 30, 2022 |
-2.00 |
| Jun 30, 2022 |
-783.00 |
| Mar 31, 2022 |
-486.00 |
| Dec 31, 2021 |
1,242.00 |
| Sep 30, 2021 |
-185.00 |
| Jun 30, 2021 |
118.00 |
